Home
Gland Pharma Ltd EPS

Gland Pharma Ltd
NSE: GLAND
EPS
Key Highlights
- The Earning per Share of Gland Pharma Ltd is ₹ 42.75 as of 13 May 25 .
- The earning per share of Gland Pharma Ltd changed from ₹ 11.79 to ₹ 12.42 over 7 quarters. This represents a CAGR of 3.02% .
Historical Earning per Share of Gland Pharma Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Gland Pharma Ltd
Company Fundamentals for Gland Pharma Ltd
Market Cap
23,624 Cr
EPS
42.8
P/E Ratio (TTM)
33.5
P/B Ratio (TTM)
2.7
Day’s High
1469.0
Day’s Low
1430.45
DTE
0.0
ROE
7.9
52 Week High
2220.95
52 Week Low
1200.0
ROCE
11.8
Market Price of Gland Pharma Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
13 May 2025 | 1433.9 |
12 May 2025 | 1430.6 |
09 May 2025 | 1426.3 |
08 May 2025 | 1413.5 |
07 May 2025 | 1403.45 |
06 May 2025 | 1414.2 |
05 May 2025 | 1418.75 |
02 May 2025 | 1404.7 |
30 Apr 2025 | 1398.35 |
29 Apr 2025 | 1413 |
SWOT Analysis Of Gland Pharma Ltd
BlinkX Score for Gland Pharma Ltd
Asset Value vs Market Value of Gland Pharma Ltd
Market Value
₹ 23,624
Asset Value
Value addition
3.1 X
₹ 5,704
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
Gland Pharma Ltd | 23624 | 42.75 |
Sun Pharmaceutical Industries Ltd | 407971 | 49.16 |
Divis Laboratories Ltd | 161153 | 77.86 |
Cipla Ltd | 122717 | 61.78 |
Torrent Pharmaceuticals Ltd | 109387 | 55.02 |
Mankind Pharma Ltd | 105125 | 49.48 |
Company | |
---|---|
Gland Pharma Ltd | 23624 |
Sun Pharmaceutical Industries Ltd | 407971 |
Divis Laboratories Ltd | 161153 |
Cipla Ltd | 122717 |
Torrent Pharmaceuticals Ltd | 109387 |
Mankind Pharma Ltd | 105125 |
Historical Market Cap of Gland Pharma Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Gland Pharma Ltd
Historical Revenue of Gland Pharma Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Gland Pharma Ltd
Historical EBITDA of Gland Pharma Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Gland Pharma Ltd
Historical Net Profit of Gland Pharma Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Gland Pharma Ltd
Dividend Payout Over Time
Gland Pharma Ltd News Hub
Gland Pharma slides after Q1 PAT slumps 26% YoY to Rs 144 cr
Revenue from operations jumped 15.97% YoY to Rs 1,401.70 crore in Q1 FY25. Profit before tax (PBT) s
Read more
07 Aug 24
Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter
Net profit of Gland Pharma declined 25.94% to Rs 143.76 crore in the quarter ended June 2024 as agai
Read more
06 Aug 24
US FDA issues 3 Form 483 observations to Gland Pharma's Pashamylaram facility
The said inspection was conducted between 25 July 2024 and 02 August 2024. The said inspection was c
Read more
05 Aug 24
Gland Pharma Ltd gains for third straight session
Gland Pharma Ltd gained for a third straight session today. The stock is quoting at Rs 1936.35, up 1
Read more
09 Sept 24